4.7 Review

The Adipokine-Cardiovascular-Lifestyle Network Translation to Clinical Practice

期刊

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 68, 期 16, 页码 1785-1803

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2016.06.072

关键词

cardiovascular disease; diabetes; hypertension; lifestyle medicine; network; obesity; systems biology

资金

  1. Novo Nordisk
  2. Eisai
  3. Janssen
  4. Vivus
  5. Takeda
  6. AstraZeneca
  7. Alexion
  8. Merck

向作者/读者索取更多资源

Adipokines are peptides, secreted by adipocytes and other cell types with targets in other tissues, participating in a complex network of humoral factors involved in obesity, insulin resistance, and cardiovascular (CV) disease. This review describes recent information about adipokine effects on the CV system. Rather than simply providing a listing of adipokines and their respective effects, network analysis is used to enhance understanding. Various relationships and emergent processes in the adipokine-CV system network are discussed, with the most significant interactors being responses to hypoxia, regulation of cell migration, effects on blood coagulation, and platelet activation. Clinical translation is provided through network representations of the obesity paradox, metabolically healthy obese, metabolic syndrome, and beneficial role of lifestyle medicine. As more translatable information about the larger adipokine-CV-lifestyle network is acquired from laboratory and clinical research, the strategic and precise role of lifestyle intervention can be fashioned to improve CV outcomes. (C) 2016 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据